Application of PARP1-Specific Pt(II)-Based Targeted Drug Conjugate in the Treatment of Ovarian Cancer by Inhibiting PARP1 and Suppressing DNA Damage Repair

Journal:
Inorganic Chemistry
Published:
DOI:
10.1021/acs.inorgchem.6c00964
Affiliations:
2
Authors:
3
Go to article
Institutions Authors Share
Southeast University (SEU), China
2.500000
 0.83
Jinan University (JNU), China
0.500000
 0.17
Interested in Oncology and Carcinogenesis?